688198 佰仁医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.78011.95910.0359.0995.606
总资产报酬率 ROA (%)4.95010.6129.1918.6055.383
投入资产回报率 ROIC (%)5.45511.6469.8859.0375.570

边际利润分析
销售毛利率 (%)88.54288.33989.84589.37588.243
营业利润率 (%)32.61730.52932.59836.39320.892
息税前利润/营业总收入 (%)30.50028.68232.36235.62919.208
净利润/营业总收入 (%)26.39226.33029.51931.98020.357

收益指标分析
经营活动净收益/利润总额(%)76.86892.60083.47279.29164.941
价值变动净收益/利润总额(%)6.3447.13214.89321.01431.953
营业外收支净额/利润总额(%)-5.884-1.614-0.668-1.209-5.735

偿债能力分析
流动比率 (X)3.3245.1708.42911.45123.311
速动比率 (X)2.9074.7087.99610.95322.711
资产负债率 (%)16.78112.59910.4346.8224.145
带息债务/全部投入资本 (%)2.413-2.206-2.432-0.9430.136
股东权益/带息债务 (%)3,802.238-4,401.002-4,017.473-10,542.42872,852.436
股东权益/负债合计 (%)499.184694.817862.7531,368.3902,315.807
利息保障倍数 (X)-100.100-21.058-1,704.972-108.218-34.876

营运能力分析
应收账款周转天数 (天)84.40973.54068.70559.99148.881
存货周转天数 (天)386.194269.552317.476306.770232.915